ImmunityBio

4 atoms · 跨 1 天 · 首见 2026-05-16 · 最近 2026-05-16

三色: 🟦 fact 4 · 🟥 take 0 · stance ▲0/▼0/◆4

来源: X 4

时态: fresh:4

标签: 好信源:4

预测 (forecast) (1)

• 2026-05-16 · 计划FDA沟通和BLA提交
  ImmunityBio plans FDA engagement and BLA submission using S1602 data.
  tags: 好信源 · → daily

事实 (fact) (3)

• 2026-05-16 · 签署美国独家协议
  ImmunityBio signs exclusive U.S. agreement with Japan BCG Laboratory.
  tags: 好信源 · → daily
• 2026-05-16 · 协议覆盖开发和商业化
  Agreement covers development and commercialization of Tokyo-172 BCG.
  tags: 好信源 · → daily
• 2026-05-16 · 产品处于研究阶段未获FDA批准
  Product remains investigational and unapproved by the FDA in the U.S.
  tags: 好信源 · → daily

时间轴 (近 20)

• 2026-05-16 · fact · 签署美国独家协议 · → daily
• 2026-05-16 · fact · 协议覆盖开发和商业化 · → daily
• 2026-05-16 · fact · 产品处于研究阶段未获FDA批准 · → daily
• 2026-05-16 · forecast · 计划FDA沟通和BLA提交 · → daily

← 实体目录 · 系统日志